Carotid Artery Stent Placement Article

Full Text via DOI: 10.1016/j.jcin.2010.04.002 PMID: 20488401 Web of Science: 000278083300001

Cited authors

  • White, Christopher J.


  • In the past 3 years, there have been significant developments in the field of carotid revascularization, including: 1) the results of a large primary stroke prevention trial; 2) the emergence of novel platforms for emboli protection; 3) improved characterization of the high-risk carotid artery stent (CAS) patient; 4) completion of several very large post-market surveillance (PMS) trials of CAS in high-surgical-risk patients; and 5) the completion of 4 large randomized controlled trials comparing CAS with carotid endarterectomy in average-risk patients. The purpose of this review is to update the current status of revascularization therapies to reduce stroke in patients with extracranial carotid artery disease with a focus on the most recent developments regarding the role of CAS. (J Am Coll Cardiol Intv 2010;3: 467-74) (C) 2010 by the American College of Cardiology Foundation

Publication date

  • 2010

Published in

International Standard Serial Number (ISSN)

  • 1936-8798

Start page

  • 467

End page

  • 474


  • 3


  • 5